Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Item No. 33479

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9 LPA) is intended for use as an internal standard for the quantification of 1-palmitoyl LPA (Item Nos. 10010094 | 10010290) by GC- or LC-MS. 1-Palmitoyl LPA is an analog of LPA that contains palmitic acid (Item No. 10006627) at the sn-1 position. It induces reporter gene expression in PC12 cells expressing human lysophosphatidic acid receptor 4 (LPA4) when used at concentrations ranging from 0.01 to 10 µM.1 1-Palmitoyl LPA (12-300 µM) induces aggregation of isolated human platelets, an effect that can be reversed by prostaglandin E1 (PGE1; Item No. 13010), theophylline (Item No. 23760), or EDTA.2 It also binds to calcium and magnesium and enhances the activity of ampicillin (Item No. 14417), piperacillin (Item No. 20766), and ceftazidime (Item No. 14828) against P. aeruginosa isolates from patients with cystic fibrosis.3
WARNING This product is not for human or veterinary use.
1. Identification of p2y9/GPR23 as a novel G protein-
2. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. Am. J. Pathol. 96(2), 423-438 (1979).
3. Specific phospholipids enhance the activity of β-